Duke-NCCU collaboration secures follow-on funding from NC Biotech Center

The North Carolina Biotechnology Center, located in Research Triangle Park, helps bring scientific ideas to market.
A collaborative research team supported by Duke CTSI has secured follow-on funding from the North Carolina Biotechnology Center for their work in drug delivery.
The project, “Engineering smart injectable drug delivery theranostics for uterine fibroids” is led by Frederike Jayes, DVM, PhD as the Duke Principal Investigator (PI) on the project, and Darlene Taylor, PhD as the NCCU PI.
The team’s funding period from NC Biotech Center runs from February 2021 to February 2022, and will advance research on a hydrogel for controlled release of drugs used in uterine fibroid therapy.